Holen Sie sich die Stockscreener-App
2.44
1.21%
-0.03
Handel nachbörslich:
2.50
0.06
+2.46%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ESPR?
Forum
Prognose
Aktiensplit
Finanzdaten der Esperion Therapeutics Inc-Aktie (ESPR)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
92.93%
168.45
|
87.31 | - | 65.00 | 69.11 |
Operating Expenses
|
14.45%
83.21
|
97.27 | - | 87.09 | 73.53 |
| Benefits Costs and Expenses |
423.98
|
- | - | - | - |
| Costs And Expenses |
68.94%
164.33
|
97.27 | - | 87.09 | 73.53 |
| Operating Income/Loss |
955.84%
85.23
|
-9.959 | - | -22.10 | -4.42 |
| Income/Loss From Continuing Operations Before Tax |
392.67%
-255.53
|
87.31 | -12.72 | -40.45 | 69.11 |
| Income Tax Expense/Benefit |
1.841
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
297.34%
61.83
|
-31.33 | -12.72 | -40.45 | -21.32 |
|
Net Income/Loss
|
297.34%
61.83
|
-31.33 | -12.72 | -40.45 | -21.32 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
95.16%
9.7114
|
200.74 | - | 196.13 | 2.8154 |
| Diluted Average Shares |
95.16%
9.7114
|
200.74 | - | 196.13 | 2.8154 |
| Basic Earnings Per Share |
300.00%
0.32
|
-0.16 | - | -0.21 | -0.11 |
| Diluted Earnings Per Share |
300.00%
0.32
|
-0.16 | - | -0.21 | -0.11 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.15%
3.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):